Barry Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
+209
New +$214K 0.05% 86
2026
Q1
Sell
-303
Closed -$325K 105
2025
Q4
$325K Buy
+303
New +$290K 0.07% 70

Other funds holding LLY

Barry Investment Advisors's LLY Position: Q2 2026 in Review

Barry Investment Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 209 shares worth $250K. The stake represents 0.05% of the portfolio and ranks #86 among its holdings. This is a return to the name: Barry Investment Advisors previously reported a position in LLY as recently as Q4 2025.

Barry Investment Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $325K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Barry Investment Advisors held 209 shares of Eli Lilly worth $250K as of Q2 2026.
  • Eli Lilly was a new Barry Investment Advisors position in Q2 2026.
  • Eli Lilly made up 0.05% of Barry Investment Advisors's portfolio in Q2 2026, its #86 holding.
  • Barry Investment Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Barry Investment Advisors's Eli Lilly position peaked at $325K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.